Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography: Increased valvular fluorodeoxyglucose uptake in aortic stenosis

Journal of the American College of Cardiology

Volumn 57, Issue 25, 2011, Pages 2507-2515

  Marincheva Savcheva, Gergana ^a   Subramanian, Sharath ^a   Qadir, Sadia ^a   Figueroa, Amparo ^a   Truong, Quynh ^a   Vijayakumar, Jayanthi ^a   Brady, Thomas J ^a   Hoffmann, Udo ^a   Tawakol, Ahmed ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

aortic stenosis; cardiac imaging; FDG PET; inflammation

Indexed keywords

FLUORODEOXYGLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; AORTA VALVE STENOSIS; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEX RATIO; SIGNAL NOISE RATIO;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 79958841743     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.12.046     Document Type: Article

References (34)

1. C.M. Otto, J. Kuusisto, D.D. Reichenbach, A.M. Gown, and K.D. O'Brien Characterization of the early lesion of 'degenerative' valvular aortic stenosis Histological and immunohistochemical studies Circulation 90 1994 844 853 (Pubitemid 24242754)
2. M. Olsson, C.J. Dalsgaard, A. Haegerstrand, M. Rosenqvist, L. Ryden, and J. Nilsson Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves J Am Coll Cardiol 23 1994 1162 1170 (Pubitemid 24117151)
3. N.M. Rajamannan, M. Subramaniam, and D. Rickard Human aortic valve calcification is associated with an osteoblast phenotype Circulation 107 2003 2181 2184 (Pubitemid 36547209)
4. R.V. Freeman, and C.M. Otto Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies Circulation 111 2005 3316 3326 (Pubitemid 40875006)
5. J. Lorenzen, R. Buchert, and K.H. Bohuslavizki Value of FDG PET in patients with fever of unknown origin Nucl Med Commun 22 2001 779 783 (Pubitemid 32613439)
6. Y. Sugawara, T.D. Gutowski, S.J. Fisher, R.S. Brown, and R.L. Wahl Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA Eur J Nucl Med 26 1999 333 341 (Pubitemid 29176443)
7. C.P. Bleeker-Rovers, F.J. Vos, and G.J. Wanten 18F-FDG PET in detecting metastatic infectious disease J Nucl Med 46 2005 2014 2019 (Pubitemid 46657448)
8. A.H. Kaim, B. Weber, M.O. Kurrer, J. Gottschalk, G.K. Von Schulthess, and A. Buck Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats Radiology 223 2002 446 451 (Pubitemid 34454324)
9. A. Tawakol, R.Q. Migrino, and U. Hoffmann Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography J Nucl Cardiol 12 2005 294 301 (Pubitemid 40790404)
10. J.H. Rudd, E.A. Warburton, and T.D. Fryer Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711 (Pubitemid 34615139)
11. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831 (Pubitemid 44648621)
12. J.H. Rudd, K.S. Myers, and S. Bansilal (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials J Am Coll Cardiol 50 2007 892 896 (Pubitemid 47268746)
13. A. Tawakol, R.Q. Migrino, and G.G. Bashian In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824 (Pubitemid 44648622)
14. I.S. Rogers, K. Nasir, and A.L. Figueroa Feasibility of FDG imaging of the coronary arteries: comparison between patients with acute coronary syndromes and stable angina J Am Coll Cardiol Img 3 2010 388 397
15. R.O. Bonow, B.A. Carabello, and K. Chatterjee ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 2006 e1 e148
16. J.K. Willmann, D. Weishaupt, and M. Lachat Electrocardiographically gated multi-detector row CT for assessment of valvular morphology and calcification in aortic stenosis Radiology 225 2002 120 128
17. E. Aikawa, M. Nahrendorf, and J.L. Figueiredo Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo Circulation 116 2007 2841 2850 (Pubitemid 350301146)
18. R. Ross Atherosclerosisan inflammatory disease N Engl J Med 340 1999 115 126
19. M.L. Gronholdt, B.G. Nordestgaard, and J. Bentzon Macrophages are associated with lipid-rich carotid artery plaques, echolucency on B-mode imaging, and elevated plasma lipid levels J Vasc Surg 35 2002 137 145 (Pubitemid 44725782)
20. C.M. Wahlgren, W. Zheng, W. Shaalan, J. Tang, and H.S. Bassiouny Human carotid plaque calcification and vulnerability Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology Cerebrovasc Dis 27 2009 193 200
21. J.H. Rudd, K.S. Myers, and S. Bansilal Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 2009 107 115
22. E. Aikawa, M. Nahrendorf, and D. Sosnovik Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease Circulation 115 2007 377 386 (Pubitemid 46148512)
23. S.J. Sui, M.Y. Ren, F.Y. Xu, and Y. Zhang A high association of aortic valve sclerosis detected by transthoracic echocardiography with coronary arteriosclerosis Cardiology 108 2007 322 330 (Pubitemid 350126478)
24. A. Mazzone, M.C. Epistolato, and J. Gianetti Biologic features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease? Am J Clin Pathol 126 2006 494 502 (Pubitemid 44498498)
25. E.R. Mohler 3rd Mechanisms of aortic valve calcification Am J Cardiol 94 2004 1396 1402 A6
26. G.M. Novaro, R. Katz, and R.J. Aviles Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study J Am Coll Cardiol 50 2007 1992 1998 (Pubitemid 350046337)
27. P.H. Stone C-reactive protein to identify early risk for development of calcific aortic stenosis: right marker? Wrong time? J Am Coll Cardiol 50 2007 1999 2001
28. G.M. Novaro, I.Y. Tiong, G.L. Pearce, M.S. Lauer, D.L. Sprecher, and B.P. Griffin Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis Circulation 104 2001 2205 2209 (Pubitemid 33043301)
29. D.M. Shavelle, J. Takasu, M.J. Budoff, S. Mao, X.Q. Zhao, and K.D. O'Brien HMG CoA reductase inhibitor (statin) and aortic valve calcium Lancet 359 2002 1125 1126 (Pubitemid 34270741)
30. W.S. Aronow, C. Ahn, I. Kronzon, and M.E. Goldman Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons Am J Cardiol 88 2001 693 695 (Pubitemid 32831111)
31. R. Rosenhek, F. Rader, and N. Loho Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 110 2004 1291 1295 (Pubitemid 39202347)
32. S.J. Cowell, D.E. Newby, and R.J. Prescott A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397 (Pubitemid 40958435)
33. A.B. Rossebo, T.R. Pedersen, and K. Boman Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
34. K.L. Chan, K. Teo, J.G. Dumesnil, A. Ni, and J. Tam Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314